BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients

BACKGROUND: Anaplastic thyroid carcinoma (ATC) is the most aggressive cancer in humans with no optimal treatment strategy available. The molecular mechanisms of ATC remain unclear. The aim of this study was to investigate the prognostic value and role of BRMS1 in the progression of ATC. METHODS: BRM...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Onco Targets Ther
Hauptverfasser: Wu, Yu, Wang, Huijuan, Zhi, Jingtai, Hu, Linfei, Hou, Xiukun, Ruan, Xianhui, Zheng, Xiangqian, Liu, Hui, Gao, Ming
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove 2019
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6718127/
https://ncbi.nlm.nih.gov/pubmed/31695409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S219506
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge